USANA HEALTH SCIENCES INC (USNA) — SEC Financial Statements & Analysis

USANA HEALTH SCIENCES INC (USNA) is a medicinal chemicals & botanical products company, incorporated in UT. USANA HEALTH SCIENCES INC trades on NYSE as: USNA. USANA HEALTH SCIENCES INC (USNA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, USANA HEALTH SCIENCES INC carries a market cap of $394.68M, a P/E ratio of -16.87x, a P/B ratio of 0.75x, a P/S ratio of 0.43x, an enterprise value of $226.12M, and an EV/EBITDA multiple of 7.21x. On profitability, it posts a gross margin of 77.45%, an operating margin of -0.12%, a net margin of -2.56%, a Return on Equity (ROE) of -4.43%, a Return on Assets (ROA) of -3.25%, and a Return on Invested Capital (ROIC) of 0.00%. Per share, it reports EPS of $-1.27, diluted EPS of $-1.27, free cash flow per share of $0.86, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 1.57% year-over-year, net income growth of -167.24% year-over-year, and EPS growth of -167.34% year-over-year. On the balance sheet, it maintains a current ratio of 2.66x, a quick ratio of 1.63x, working capital of $175.39M, a debt-to-equity ratio of 0.25x, a debt ratio of 0.19, an interest coverage ratio of -2.62x, free cash flow of $15.93M (TTM), and net debt of $-168.56M. Figures sourced from SEC EDGAR.

Market Cap

$394.68M

P/E TTM

-16.87x

EPS TTM

$-1.27

P/B TTM

0.75x

ROE TTM

-4.43%

ROA TTM

-3.25%

Debt To Equity

0.25x

Free Cash Flow TTM

$15.93M

Net Revenue TTM Growth 1Y

1.57%

Data as of 2026-06-30 · Source: SEC EDGAR